FDA jeopardizes the lives of lung transplant recipients and in the process severely increases the cost to develop new immunosuppression

Goran B. Klintmalm*, Bruce Kaplan, Allan D. Kirk

*Corresponding author for this work

Research output: Contribution to journal › Editorial

4 Scopus citations

Fingerprint

Dive into the research topics of 'FDA jeopardizes the lives of lung transplant recipients and in the process severely increases the cost to develop new immunosuppression'. Together they form a unique fingerprint.

Medicine & Life Sciences